Citadel Advisors - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 22 filers reported holding TRINITY BIOTECH PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q2 2023$40,560
+53.2%
42,022
+49.2%
0.00%
Q1 2023$26,481
+47.1%
28,171
+61.9%
0.00%
Q1 2022$18,000
-66.7%
17,400
-54.2%
0.00%
Q4 2021$54,000
-34.9%
37,984
-1.7%
0.00%
Q3 2021$83,000
-69.3%
38,644
-57.9%
0.00%
Q2 2021$270,000
+0.7%
91,784
+28.1%
0.00%
Q1 2021$268,000
+312.3%
71,649
+319.0%
0.00%
Q4 2020$65,000
-57.2%
17,100
-77.3%
0.00%
Q3 2020$152,000
+137.5%
75,479
+157.6%
0.00%
Q2 2020$64,000
-35.4%
29,306
+104.9%
0.00%
Q4 2016$99,000
-35.3%
14,302
+8.8%
0.00%
Q1 2016$153,000
-82.8%
13,144
-71.6%
0.00%
-100.0%
Q1 2015$892,000
+8.4%
46,335
-1.4%
0.00%0.0%
Q4 2014$823,000
+21.0%
46,985
+26.3%
0.00%0.0%
Q3 2014$680,000
+0.1%
37,195
+26.1%
0.00%0.0%
Q2 2014$679,000
+55.7%
29,491
+64.1%
0.00%0.0%
Q1 2014$436,000
+87.1%
17,969
+94.4%
0.00%
Q4 2013$233,0009,2450.00%
Other shareholders
TRINITY BIOTECH PLC shareholders Q2 2022
NameSharesValueWeighting ↓
Lyon Street Capital, LLC 739,669$13,514,0006.33%
ACK Asset Management 749,867$13,700,0004.92%
CASTLEROCK ASSET MANAGEMENT INC 26,751$489,0004.12%
GOLDMAN CAPITAL MANAGEMENT INC 309,297$5,651,0002.83%
Paradice Investment Management LLC 348,686$6,370,0001.66%
Park West Asset Management LLC 600,770$10,976,0001.62%
Adirondack Research & Management Inc. 220,638$4,031,0001.50%
RK Capital 375,043$6,852,0001.40%
KEANE CAPITAL MANAGEMENT INC 70,000$1,279,0001.23%
CARDINAL CAPITAL MANAGEMENT LLC /CT 953,618$17,423,0001.08%
View complete list of TRINITY BIOTECH PLC shareholders